Oligo-fucoidan

DIETARY_SUPPLEMENT2 trials

Sponsors

Mayo Clinic, Hi-Q Marine Biotech International Ltd.

Conditions

Chronic Respiratory Diseases PM2.5, chronic respiratory diseases, oligo-fucoidan, immune responses, inflammation.Malignant Digestive System NeoplasmMalignant Female Reproductive System Neoplasm

Early Phase 1

The Effects of Oilgo-Fucoidan on Immune Status, Inflammato-ry Response, and Heavy Metal Concentrations in Patients with Chronic Respiratory Diseases Associated with Air Pollution in Central Taiwan

Active, not recruitingTCTR20260126009

Hi-Q Marine Biotech International Ltd.Chronic Respiratory Diseases PM2.5, chronic respiratory diseases, oligo-fucoidan, immune responses, inflammation.

Start: 2022-01-22Target: 60Updated: 2026-08-03

Phase 2

Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal or Gynecological Cancer

RecruitingNCT06855524

Mayo ClinicMalignant Digestive System Neoplasm, Malignant Female Reproductive System Neoplasm

Start: 2025-03-06End: 2027-02-28Target: 34Updated: 2026-02-24